1. Home
  2. PYXS vs HNNA Comparison

PYXS vs HNNA Comparison

Compare PYXS & HNNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PYXS
  • HNNA
  • Stock Information
  • Founded
  • PYXS 2018
  • HNNA 1989
  • Country
  • PYXS United States
  • HNNA United States
  • Employees
  • PYXS N/A
  • HNNA N/A
  • Industry
  • PYXS Biotechnology: Pharmaceutical Preparations
  • HNNA Investment Managers
  • Sector
  • PYXS Health Care
  • HNNA Finance
  • Exchange
  • PYXS Nasdaq
  • HNNA Nasdaq
  • Market Cap
  • PYXS 79.4M
  • HNNA 78.3M
  • IPO Year
  • PYXS 2021
  • HNNA N/A
  • Fundamental
  • Price
  • PYXS $3.48
  • HNNA $9.53
  • Analyst Decision
  • PYXS Strong Buy
  • HNNA
  • Analyst Count
  • PYXS 5
  • HNNA 0
  • Target Price
  • PYXS $7.75
  • HNNA N/A
  • AVG Volume (30 Days)
  • PYXS 877.2K
  • HNNA 14.0K
  • Earning Date
  • PYXS 11-11-2025
  • HNNA 12-10-2025
  • Dividend Yield
  • PYXS N/A
  • HNNA 5.77%
  • EPS Growth
  • PYXS N/A
  • HNNA 56.56
  • EPS
  • PYXS N/A
  • HNNA 1.25
  • Revenue
  • PYXS $2,820,000.00
  • HNNA $35,816,000.00
  • Revenue This Year
  • PYXS N/A
  • HNNA N/A
  • Revenue Next Year
  • PYXS N/A
  • HNNA N/A
  • P/E Ratio
  • PYXS N/A
  • HNNA $7.64
  • Revenue Growth
  • PYXS N/A
  • HNNA 32.04
  • 52 Week Low
  • PYXS $0.83
  • HNNA $8.43
  • 52 Week High
  • PYXS $5.39
  • HNNA $13.88
  • Technical
  • Relative Strength Index (RSI)
  • PYXS 60.49
  • HNNA 34.40
  • Support Level
  • PYXS $3.17
  • HNNA $9.13
  • Resistance Level
  • PYXS $3.75
  • HNNA $9.59
  • Average True Range (ATR)
  • PYXS 0.31
  • HNNA 0.38
  • MACD
  • PYXS -0.05
  • HNNA -0.02
  • Stochastic Oscillator
  • PYXS 33.62
  • HNNA 29.79

About PYXS Pyxis Oncology Inc.

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.

About HNNA Hennessy Advisors Inc.

Hennessy Advisors Inc is an investment management company, engaged in the managing and marketing of open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, sectors, and specialty, balanced, and fixed income products. It also provides investment advisory services and shareholder services to the Hennessy Funds which include managing the composition of each fund's portfolio, including the purchase, retention, and disposition of portfolio securities as per the Fund's investment objectives, policies, and restrictions; conducting investment research, and monitoring compliance with each fund's investment restrictions and applicable laws and regulations.

Share on Social Networks: